38 Evaluation of minimal Factor H therapy administered to kidneys during ex vivo normothermic perfusion as a treatment to improve ischaemia reperfusion injury (2023)
Attributed to:
Using minimal Factor H therapy and normothermic conditions to prepare kidneys for transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.imbio.2023.152492
Publication URI: http://dx.doi.org/10.1016/j.imbio.2023.152492
Type: Journal Article/Review
Parent Publication: Immunobiology
Issue: 5